Global Closed-loop Automated Insulin Delivery (AID) System Market Growth 2024-2030

Global Closed-loop Automated Insulin Delivery (AID) System Market Growth 2024-2030

Automated Insulin Delivery (AID) systems automatically adjust insulin delivery to help control blood glucose levels, reduce hypoglycemia, and increase time in range. AID systems are often called hybrid closed loop systems and allow for a complete circle of communication between a continuous glucose monitor (CGM) and insulin Pod/pump.

The global Closed-loop Automated Insulin Delivery (AID) System market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

LP Information, Inc. (LPI) ' newest research report, the “Closed-loop Automated Insulin Delivery (AID) System Industry Forecast” looks at past sales and reviews total world Closed-loop Automated Insulin Delivery (AID) System sales in 2023, providing a comprehensive analysis by region and market sector of projected Closed-loop Automated Insulin Delivery (AID) System sales for 2024 through 2030. With Closed-loop Automated Insulin Delivery (AID) System sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Closed-loop Automated Insulin Delivery (AID) System industry.

This Insight Report provides a comprehensive analysis of the global Closed-loop Automated Insulin Delivery (AID) System landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Closed-loop Automated Insulin Delivery (AID) System portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Closed-loop Automated Insulin Delivery (AID) System market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Closed-loop Automated Insulin Delivery (AID) System and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Closed-loop Automated Insulin Delivery (AID) System.

United States market for Closed-loop Automated Insulin Delivery (AID) System is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Closed-loop Automated Insulin Delivery (AID) System is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Closed-loop Automated Insulin Delivery (AID) System is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Closed-loop Automated Insulin Delivery (AID) System players cover Medtronic, Tandem Diabetes Care, Admetsys, Insulet, Defymed, etc. In terms of revenue, the global two largest companies occupied for a share nearly

% in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Closed-loop Automated Insulin Delivery (AID) System market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Hybrid Closed Loop Systems
DIY Closed Loop Systems

Segmentation by Application:
Children with Type 1 Diabetes
Adults with Type 1 Diabetes

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Medtronic
Tandem Diabetes Care
Admetsys
Insulet
Defymed
Beta Bionics (iLet)
Bigfoot Biomedical
Dexcom
MicroTech Medical (Hangzhou) Co., Ltd.
Medtrum

Key Questions Addressed in this Report

What is the 10-year outlook for the global Closed-loop Automated Insulin Delivery (AID) System market?

What factors are driving Closed-loop Automated Insulin Delivery (AID) System market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Closed-loop Automated Insulin Delivery (AID) System market opportunities vary by end market size?

How does Closed-loop Automated Insulin Delivery (AID) System break out by Type, by Application?



Please note: The report will take approximately 2 business days to prepare and deliver.